文章类型：指南原文

语言：英文

中文标题：2012年 EDF 《特应性湿疹（特应性皮炎）治疗指南》（第1部分）

英文标题：Guidelines for treatment of atopic eczema (atopic dermatitis) partⅠ

制定者：欧洲皮肤病学论坛(EDF,European Dermatology Forum)

制定日期：2012.8.1

摘要：The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin inhibitors (TCI) is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the TCI tacrolimus and pimecrolimus are preferred in certain locations. Systemic immune-suppressive treatment is an option for severe refractory cases.

本文下载链接见下方。